<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Springer-Verlag</PublisherName>
    <PublisherLocation>New York</PublisherLocation>
  </PublisherInfo>
  <Journal>
    <JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered">
      <JournalID>12248</JournalID>
      <JournalElectronicISSN>1550-7416</JournalElectronicISSN>
      <JournalTitle>The AAPS Journal</JournalTitle>
      <JournalAbbreviatedTitle>AAPS J</JournalAbbreviatedTitle>
      <JournalSubjectGroup>
        <JournalSubject Code="F" Type="Primary">Pharmacy</JournalSubject>
        <JournalSubject Code="F00008" Priority="1" Type="Secondary">Pharmacy</JournalSubject>
        <JournalSubject Code="B21007" Priority="2" Type="Secondary">Pharmacology/Toxicology</JournalSubject>
        <JournalSubject Code="C12002" Priority="3" Type="Secondary">Biotechnology</JournalSubject>
      </JournalSubjectGroup>
    </JournalInfo>
    <Volume>
      <VolumeInfo TocLevels="0" VolumeType="Regular">
        <VolumeIDStart>7</VolumeIDStart>
        <VolumeIDEnd>7</VolumeIDEnd>
        <VolumeIssueCount>4</VolumeIssueCount>
      </VolumeInfo>
      <Issue IssueType="Regular">
        <IssueInfo TocLevels="0">
          <IssueIDStart>2</IssueIDStart>
          <IssueIDEnd>2</IssueIDEnd>
          <IssueArticleCount>25</IssueArticleCount>
          <IssueHistory>
            <CoverDate>
              <Year>2005</Year>
              <Month>6</Month>
            </CoverDate>
          </IssueHistory>
          <IssueCopyright>
            <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
            <CopyrightYear>2005</CopyrightYear>
          </IssueCopyright>
        </IssueInfo>
        <Article ID="Art17">
          <ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
            <ArticleID>72421</ArticleID>
            <ArticleDOI>10.1208/aapsj070242</ArticleDOI>
            <ArticleSequenceNumber>17</ArticleSequenceNumber>
            <ArticleTitle Language="En">Serotonin transporters: Implications for antidepressant drug development</ArticleTitle>
            <ArticleFirstPage>E421</ArticleFirstPage>
            <ArticleLastPage>E433</ArticleLastPage>
            <ArticleHistory>
              <RegistrationDate>
                <Year>2008</Year>
                <Month>1</Month>
                <Day>23</Day>
              </RegistrationDate>
              <Received>
                <Year>2005</Year>
                <Month>3</Month>
                <Day>9</Day>
              </Received>
              <Accepted>
                <Year>2005</Year>
                <Month>5</Month>
                <Day>30</Day>
              </Accepted>
            </ArticleHistory>
            <ArticleCopyright>
              <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
              <CopyrightYear>2005</CopyrightYear>
            </ArticleCopyright>
            <ArticleGrants Type="Regular">
              <MetadataGrant Grant="OpenAccess"/>
              <AbstractGrant Grant="OpenAccess"/>
              <BodyPDFGrant Grant="Restricted"/>
              <BodyHTMLGrant Grant="Restricted"/>
              <BibliographyGrant Grant="Restricted"/>
              <ESMGrant Grant="Restricted"/>
            </ArticleGrants>
            <ArticleContext>
              <JournalID>12248</JournalID>
              <VolumeIDStart>7</VolumeIDStart>
              <VolumeIDEnd>7</VolumeIDEnd>
              <IssueIDStart>2</IssueIDStart>
              <IssueIDEnd>2</IssueIDEnd>
            </ArticleContext>
          </ArticleInfo>
          <ArticleHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Kellie</GivenName>
                  <GivenName>J.</GivenName>
                  <FamilyName>White</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Crystal</GivenName>
                  <GivenName>C.</GivenName>
                  <FamilyName>Walline</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Eric</GivenName>
                  <GivenName>L.</GivenName>
                  <FamilyName>Barker</FamilyName>
                </AuthorName>
                <Contact>
                  <Phone>(765) 494-9940</Phone>
                  <Fax>(765) 494-1414</Fax>
                  <Email>ericb@pharmacy.purdue.edu</Email>
                </Contact>
              </Author>
              <Affiliation ID="Aff1">
                <OrgDivision>Dept. of Medicinal Chemistry and Molecular Pharmacology</OrgDivision>
                <OrgName>Purdue University School of Pharmacy</OrgName>
                <OrgAddress>
                  <Street>575 Stadium Mall Drive</Street>
                  <Postcode>47907</Postcode>
                  <City>West Lafayette</City>
                  <State>IN</State>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1" Language="En">
              <Heading>Abstract</Heading>
              <Para>Due to the complexity of the disease, several hypotheses exist to explain the etiology of depression. The monoamine theory of depression suggests that disruptions in the serotonergic and noradrenergic systems result in depressive symptoms. Therefore, the serotonin transporter (SERT) has become a pharmacological target for treating these symptoms. This review will discuss what is known about the molecular interactions of antidepressants with SERT. The effects of antidepressants on SERT regulation and expression in addition to the receptors that may be involved in mediating these effects will be addressed. Specifically, how changes to SERT expression following chronic antidepressant treatment may contribute to the therapeutic benefits of antidepressants will be discussed. Furthermore, the effects of<Emphasis Type="Italic">SERT</Emphasis> gene polymorphisms on antidepressant efficacy will be examined. Finally, a brief overview of other hypotheses of depression will be addressed as well as factors that must be considered for future antidepressant development.</Para>
            </Abstract>
            <KeywordGroup Language="En">
              <Heading>Keywords</Heading>
              <Keyword>SSRIs</Keyword>
              <Keyword>antidepressant</Keyword>
              <Keyword>serotonin transporter</Keyword>
              <Keyword>depression</Keyword>
              <Keyword>reuptake</Keyword>
            </KeywordGroup>
            <ArticleNote Type="Misc">
              <SimplePara>Published: October 5, 2005</SimplePara>
            </ArticleNote>
          </ArticleHeader>
          <BodyRef FileRef="BodyRef/PDF/12248_2008_Article_72421.pdf" TargetType="OnlinePDF"/>
          <ArticleBackmatter>
            <Bibliography ID="Bib1">
              <Heading>References</Heading>
              <Citation ID="CR1">
                <CitationNumber>1.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>GR</Initials>
                    <FamilyName>Heninger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PL</Initials>
                    <FamilyName>Delgado</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DS</Initials>
                    <FamilyName>Charney</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans</ArticleTitle>
                  <JournalTitle>Pharmacopsychiatry</JournalTitle>
                  <VolumeID>29</VolumeID>
                  <FirstPage>2</FirstPage>
                  <LastPage>11</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8852528</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXjs1Cgu7g%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1055/s-2007-979535</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Heninger GR, Delgado PL, Charney DS. The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans.<Emphasis Type="Italic">Pharmacopsychiatry</Emphasis>. 1996;29:2–11.</BibUnstructured>
              </Citation>
              <Citation ID="CR2">
                <CitationNumber>2.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DJ</Initials>
                    <FamilyName>Nutt</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">The neuropharmacology of serotonin and noradrenaline in depression</ArticleTitle>
                  <JournalTitle>Int Clin Psychopharmacol</JournalTitle>
                  <VolumeID>17</VolumeID>
                  <FirstPage>S1</FirstPage>
                  <LastPage>S12</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12369606</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1097/00004850-200201000-00001</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Nutt DJ. The neuropharmacology of serotonin and noradrenaline in depression.<Emphasis Type="Italic">Int Clin Psychopharmacol</Emphasis>. 2002;17:S1-S12.</BibUnstructured>
              </Citation>
              <Citation ID="CR3">
                <CitationNumber>3.</CitationNumber>
                <BibChapter>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Rush</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Ryan</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ChapterTitle Language="En">Current and emerging therapeutics for depression</ChapterTitle>
                  <BibEditorName>
                    <Initials>K</Initials>
                    <FamilyName>Davis</FamilyName>
                  </BibEditorName>
                  <BibEditorName>
                    <Initials>D</Initials>
                    <FamilyName>Charney</FamilyName>
                  </BibEditorName>
                  <BibEditorName>
                    <Initials>J</Initials>
                    <FamilyName>Coyle</FamilyName>
                  </BibEditorName>
                  <BibEditorName>
                    <Initials>C</Initials>
                    <FamilyName>Nemeroff</FamilyName>
                  </BibEditorName>
                  <Eds/>
                  <BookTitle>Neuropsychopharmacology: The Fifth Generation of Progress</BookTitle>
                  <PublisherName>Raven Press</PublisherName>
                  <PublisherLocation>New York</PublisherLocation>
                  <FirstPage>1081</FirstPage>
                  <LastPage>1095</LastPage>
                </BibChapter>
                <BibUnstructured>Rush A, Ryan N. Current and emerging therapeutics for depression. In: Davis K, Charney D, Coyle J, Nemeroff C. eds.<Emphasis Type="Italic">Neuropsychopharmacology: The Fifth Generation of Progress</Emphasis>. New York: Raven Press; 2002:1081–1095.</BibUnstructured>
              </Citation>
              <Citation ID="CR4">
                <CitationNumber>4.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MJ</Initials>
                    <FamilyName>Owens</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WN</Initials>
                    <FamilyName>Morgan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SJ</Initials>
                    <FamilyName>Plott</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CB</Initials>
                    <FamilyName>Nemeroff</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>283</VolumeID>
                  <FirstPage>1305</FirstPage>
                  <LastPage>1322</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9400006</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXis1GmtQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Owens MJ, Morgan WN, Plott SJ, Nemeroff CB. Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 1997;283:1305–1322.</BibUnstructured>
              </Citation>
              <Citation ID="CR5">
                <CitationNumber>5.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>TA</Initials>
                    <FamilyName>Ban</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Pharmacotherapy of depression: a historical analysis</ArticleTitle>
                  <JournalTitle>J Neural Transm</JournalTitle>
                  <VolumeID>108</VolumeID>
                  <FirstPage>707</FirstPage>
                  <LastPage>716</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11478422</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/s007020170047</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXlvFKkt7w%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ban TA. Pharmacotherapy of depression: a historical analysis.<Emphasis Type="Italic">J Neural Transm</Emphasis>. 2001;108: 707–716.</BibUnstructured>
              </Citation>
              <Citation ID="CR6">
                <CitationNumber>6.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Richelson</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">The clinical relevance of antidepressant interaction with neurotransmitter transporters and receptors</ArticleTitle>
                  <JournalTitle>Psychopharmacol Bull</JournalTitle>
                  <VolumeID>36</VolumeID>
                  <FirstPage>133</FirstPage>
                  <LastPage>150</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12858153</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Richelson E. The clinical relevance of antidepressant interaction with neurotransmitter transporters and receptors.<Emphasis Type="Italic">Psychopharmacol Bull</Emphasis>. 2002;36:133–150.</BibUnstructured>
              </Citation>
              <Citation ID="CR7">
                <CitationNumber>7.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DC</Initials>
                    <FamilyName>Steffens</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KR</Initials>
                    <FamilyName>Krishnan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MJ</Initials>
                    <FamilyName>Helms</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis</ArticleTitle>
                  <JournalTitle>Depress Anxiety</JournalTitle>
                  <VolumeID>6</VolumeID>
                  <FirstPage>10</FirstPage>
                  <LastPage>18</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9394870</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/(SICI)1520-6394(1997)6:1&lt;10::AID-DA2&gt;3.0.CO;2-9</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK1c%2Fls1ymuw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Steffens DC, Krishnan KR, Helms MJ. Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis.<Emphasis Type="Italic">Depress Anxiety</Emphasis>. 1997;6:10–18.</BibUnstructured>
              </Citation>
              <Citation ID="CR8">
                <CitationNumber>8.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Song</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Freemantle</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TA</Initials>
                    <FamilyName>Sheldon</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability</ArticleTitle>
                  <JournalTitle>BMJ</JournalTitle>
                  <VolumeID>306</VolumeID>
                  <FirstPage>683</FirstPage>
                  <LastPage>687</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8471919</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK3s3ivF2qtw%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1136/bmj.306.6879.683</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Song F, Freemantle N, Sheldon TA, et al. Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.<Emphasis Type="Italic">BMJ</Emphasis>. 1993;306:683–687.</BibUnstructured>
              </Citation>
              <Citation ID="CR9">
                <CitationNumber>9.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Fava</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">New approaches to the treatment of refractory depression</ArticleTitle>
                  <JournalTitle>J Clin Psychiatry</JournalTitle>
                  <VolumeID>61</VolumeID>
                  <FirstPage>26</FirstPage>
                  <LastPage>32</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10703760</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.4088/JCP.v61n0107</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Fava M. New approaches to the treatment of refractory depression.<Emphasis Type="Italic">J Clin Psychiatry</Emphasis>. 2000;61:26–32.</BibUnstructured>
              </Citation>
              <Citation ID="CR10">
                <CitationNumber>10.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MA</Initials>
                    <FamilyName>Gutierrez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GL</Initials>
                    <FamilyName>Stimmel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JY</Initials>
                    <FamilyName>Aiso</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Venlafaxine a 2003 update</ArticleTitle>
                  <JournalTitle>Clin Ther.</JournalTitle>
                  <VolumeID>25</VolumeID>
                  <FirstPage>2138</FirstPage>
                  <LastPage>2154</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14512125</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0149-2918(03)80210-2</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXnvVWht7c%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Gutierrez MA, Stimmel GL, Aiso JY. Venlafaxine a 2003 update.<Emphasis Type="Italic">Clin Ther.</Emphasis>, 2003;25:2138–2154.</BibUnstructured>
              </Citation>
              <Citation ID="CR11">
                <CitationNumber>11.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SM</Initials>
                    <FamilyName>Stahl</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MM</Initials>
                    <FamilyName>Grady</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Differences in mechanism of action between current and future antidepressants</ArticleTitle>
                  <JournalTitle>J Clin Psychiatry</JournalTitle>
                  <VolumeID>64</VolumeID>
                  <FirstPage>13</FirstPage>
                  <LastPage>17</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14552651</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXptFSjsbs%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.4088/JCP.v64n0104</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Stahl SM, Grady MM. Differences in mechanism of action between current and future antidepressants.<Emphasis Type="Italic">J Clin Psychiatry</Emphasis>. 2003;64:13–17.</BibUnstructured>
              </Citation>
              <Citation ID="CR12">
                <CitationNumber>12.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RC</Initials>
                    <FamilyName>Shelton</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">The dual-action hypothesis: does pharmacology matter?</ArticleTitle>
                  <JournalTitle>J Clin Psychiatry</JournalTitle>
                  <VolumeID>65</VolumeID>
                  <FirstPage>5</FirstPage>
                  <LastPage>10</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15600376</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Shelton RC. The dual-action hypothesis: does pharmacology matter?.<Emphasis Type="Italic">J Clin Psychiatry</Emphasis>. 2004;65:5–10.</BibUnstructured>
              </Citation>
              <Citation ID="CR13">
                <CitationNumber>13.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>EL</Initials>
                    <FamilyName>Barker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MA</Initials>
                    <FamilyName>Perlman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EM</Initials>
                    <FamilyName>Adkins</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">High affinity recognition of serotonin transporter antagonists defined, by species-scanning mutagenesis. An aromatic residue in transmembrane domain I dictates, species-selective recognition of citalopram and mazindol</ArticleTitle>
                  <JournalTitle>J Biol Chem</JournalTitle>
                  <VolumeID>273</VolumeID>
                  <FirstPage>19459</FirstPage>
                  <LastPage>19468</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9677366</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1074/jbc.273.31.19459</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXlt1Cisbw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Barker EL, Perlman MA, Adkins EM, et al. High affinity recognition of serotonin transporter antagonists defined, by species-scanning mutagenesis. An aromatic residue in transmembrane domain I dictates, species-selective recognition of citalopram and mazindol.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 1998;273:19459–19468.</BibUnstructured>
              </Citation>
              <Citation ID="CR14">
                <CitationNumber>14.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AW</Initials>
                    <FamilyName>Ravna</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Sylte</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SG</Initials>
                    <FamilyName>Dahl</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Molecular mechanism of citalopram and cocaine interactions with neurotransmitter transporters</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>307</VolumeID>
                  <FirstPage>34</FirstPage>
                  <LastPage>41</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12944499</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/jpet.103.054593</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXnslGktL0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ravna AW, Sylte I, Dahl SG. Molecular mechanism of citalopram and cocaine interactions with neurotransmitter transporters.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2003;307:34–41.</BibUnstructured>
              </Citation>
              <Citation ID="CR15">
                <CitationNumber>15.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Kitayama</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Shimada</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Xu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Markham</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DM</Initials>
                    <FamilyName>Donovan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GR</Initials>
                    <FamilyName>Uhl</FamilyName>
                  </BibAuthorName>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>89</VolumeID>
                  <FirstPage>7782</FirstPage>
                  <LastPage>7785</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1502198</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.89.16.7782</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK38Xls1Cmtb8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kitayama S, Shimada S, Xu H, Markham L, Donovan DM, Uhl GR. Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 1992;89:7782–7785.</BibUnstructured>
              </Citation>
              <Citation ID="CR16">
                <CitationNumber>16.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>EL</Initials>
                    <FamilyName>Barker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KR</Initials>
                    <FamilyName>Moore</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Rakhshan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RD</Initials>
                    <FamilyName>Blakely</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Transmembrane domain I contributes to the permeation pathway for serotonin and ions in the serotonin transporter</ArticleTitle>
                  <JournalTitle>J Neurosci</JournalTitle>
                  <VolumeID>19</VolumeID>
                  <FirstPage>4705</FirstPage>
                  <LastPage>4717</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10366604</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXjvVCktrw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Barker EL, Moore KR, Rakhshan F, Blakely RD. Transmembrane domain I contributes to the permeation pathway for serotonin and ions in the serotonin transporter.<Emphasis Type="Italic">J Neurosci</Emphasis>. 1999;19:4705–4717.</BibUnstructured>
              </Citation>
              <Citation ID="CR17">
                <CitationNumber>17.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>FA</Initials>
                    <FamilyName>Paczkowski</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LJ</Initials>
                    <FamilyName>Bryan-Lluka</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Tyrosine residue 271 of the norepinephrine transporter is an important determinant of its pharmacology</ArticleTitle>
                  <JournalTitle>Brain Res Mol Brain Res</JournalTitle>
                  <VolumeID>97</VolumeID>
                  <FirstPage>32</FirstPage>
                  <LastPage>42</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11744160</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0169-328X(01)00295-9</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXovFyqur4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Paczkowski FA, Bryan-Lluka LJ. Tyrosine residue 271 of the norepinephrine transporter is an important determinant of its pharmacology.<Emphasis Type="Italic">Brain Res Mol Brain Res</Emphasis>. 2001;97:32–42.</BibUnstructured>
              </Citation>
              <Citation ID="CR18">
                <CitationNumber>18.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Roubert</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PJ</Initials>
                    <FamilyName>Cox</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Bruss</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Hamon</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Bonisch</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Giros</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Determination of residues in the norepinephrine transporter that are critical for tricyclic antidepressant affinity</ArticleTitle>
                  <JournalTitle>J Biol Chem</JournalTitle>
                  <VolumeID>276</VolumeID>
                  <FirstPage>8254</FirstPage>
                  <LastPage>8260</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11092898</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1074/jbc.M009798200</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXitFKgsbs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Roubert C, Cox PJ, Bruss M, Hamon M, Bonisch H, Giros B. Determination of residues in the norepinephrine transporter that are critical for tricyclic antidepressant affinity.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 2001;276:8254–8260.</BibUnstructured>
              </Citation>
              <Citation ID="CR19">
                <CitationNumber>19.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>FA</Initials>
                    <FamilyName>Paczkowski</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Bonisch</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LJ</Initials>
                    <FamilyName>Bryan-Lluka</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Pharmacological properties of the naturally occurring Ala(457)Pro variant of the human norepinephrine transporter</ArticleTitle>
                  <JournalTitle>Pharmacogenetics</JournalTitle>
                  <VolumeID>12</VolumeID>
                  <FirstPage>165</FirstPage>
                  <LastPage>173</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11875370</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1097/00008571-200203000-00010</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XnsFKqsbc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Paczkowski FA, Bonisch H, Bryan-Lluka LJ. Pharmacological properties of the naturally occurring Ala(457)Pro variant of the human norepinephrine transporter.<Emphasis Type="Italic">Pharmacogenetics</Emphasis>. 2002;12:165–173.</BibUnstructured>
              </Citation>
              <Citation ID="CR20">
                <CitationNumber>20.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DL</Initials>
                    <FamilyName>Roman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CC</Initials>
                    <FamilyName>Walline</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GJ</Initials>
                    <FamilyName>Rodriguez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EL</Initials>
                    <FamilyName>Barker</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Interactions of antidepressants with the serotonin transporter: a contemporary molecular analysis</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol</JournalTitle>
                  <VolumeID>479</VolumeID>
                  <FirstPage>53</FirstPage>
                  <LastPage>63</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14612137</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.ejphar.2003.08.056</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXovVGntLw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Roman DL, Walline CC, Rodriguez GJ, Barker EL. Interactions of antidepressants with the serotonin transporter: a contemporary molecular analysis.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 2003; 479:53–63.</BibUnstructured>
              </Citation>
              <Citation ID="CR21">
                <CitationNumber>21.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>EL</Initials>
                    <FamilyName>Barker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RD</Initials>
                    <FamilyName>Blakely</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Identification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter</ArticleTitle>
                  <JournalTitle>Mol Pharmacol</JournalTitle>
                  <VolumeID>50</VolumeID>
                  <FirstPage>957</FirstPage>
                  <LastPage>965</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8863842</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XmsFGgu7w%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Barker EL, Blakely RD. Identification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 1996;50:957–965.</BibUnstructured>
              </Citation>
              <Citation ID="CR22">
                <CitationNumber>22.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Schloss</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DC</Initials>
                    <FamilyName>Williams</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">The serotonin transporter: a primary target for antidepressant drugs</ArticleTitle>
                  <JournalTitle>J Psychopharmacol</JournalTitle>
                  <VolumeID>12</VolumeID>
                  <FirstPage>115</FirstPage>
                  <LastPage>121</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9694022</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1177/026988119801200201</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXltFGmt7c%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Schloss P, Williams DC. The serotonin transporter: a primary target for antidepressant drugs.<Emphasis Type="Italic">J Psychopharmacol</Emphasis>. 1998;12:115–121.</BibUnstructured>
              </Citation>
              <Citation ID="CR23">
                <CitationNumber>23.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Vetulani</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Nalepa</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Antidepressants: past, present and future</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol</JournalTitle>
                  <VolumeID>405</VolumeID>
                  <FirstPage>351</FirstPage>
                  <LastPage>363</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11033340</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0014-2999(00)00565-3</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXnt1Sitbg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Vetulani J, Nalepa I. Antidepressants: past, present and future.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 2000;405:351–363.</BibUnstructured>
              </Citation>
              <Citation ID="CR24">
                <CitationNumber>24.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Qian</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Galli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Ramamoorthy</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Risso</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LJ</Initials>
                    <FamilyName>DeFelice</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RD</Initials>
                    <FamilyName>Blakely</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression</ArticleTitle>
                  <JournalTitle>J Neurosci</JournalTitle>
                  <VolumeID>17</VolumeID>
                  <FirstPage>45</FirstPage>
                  <LastPage>57</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8987735</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXmsVGi</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Qian Y, Galli A, Ramamoorthy S, Risso S, DeFelice LJ, Blakely RD: Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression.<Emphasis Type="Italic">J Neurosci</Emphasis>. 1997;17:45–57.</BibUnstructured>
              </Citation>
              <Citation ID="CR25">
                <CitationNumber>25.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Ramamoorthy</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Giovanetti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Qian</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RD</Initials>
                    <FamilyName>Blakely</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Phosphorylation and regulation of antidepressant-sensitive serotonin transporters</ArticleTitle>
                  <JournalTitle>J. Biol Chem</JournalTitle>
                  <VolumeID>273</VolumeID>
                  <FirstPage>2458</FirstPage>
                  <LastPage>2466</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9442097</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1074/jbc.273.4.2458</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXnsVylsw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ramamoorthy S, Giovanetti E, Qian Y, Blakely RD. Phosphorylation and regulation of antidepressant-sensitive serotonin transporters.<Emphasis Type="Italic">J. Biol Chem</Emphasis>. 1998;273:2458–2466.</BibUnstructured>
              </Citation>
              <Citation ID="CR26">
                <CitationNumber>26.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Ramamoorthy</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RD</Initials>
                    <FamilyName>Blakely</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants</ArticleTitle>
                  <JournalTitle>Science</JournalTitle>
                  <VolumeID>285</VolumeID>
                  <FirstPage>763</FirstPage>
                  <LastPage>766</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10427004</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1126/science.285.5428.763</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXltVegsrw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ramamoorthy S, Blakely RD. Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants.<Emphasis Type="Italic">Science</Emphasis>. 1999;285:763–766.</BibUnstructured>
              </Citation>
              <Citation ID="CR27">
                <CitationNumber>27.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RJ</Initials>
                    <FamilyName>Donati</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MM</Initials>
                    <FamilyName>Rasenick</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">G protein signaling and the molecular basis of antidepressant action</ArticleTitle>
                  <JournalTitle>Life Sci</JournalTitle>
                  <VolumeID>73</VolumeID>
                  <FirstPage>1</FirstPage>
                  <LastPage>17</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12726882</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0024-3205(03)00249-2</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXjt1Kgsbs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Donati RJ, Rasenick MM. G protein signaling and the molecular basis of antidepressant action.<Emphasis Type="Italic">Life Sci</Emphasis>. 2003;73:1–17.</BibUnstructured>
              </Citation>
              <Citation ID="CR28">
                <CitationNumber>28.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Ramamoorthy</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DR</Initials>
                    <FamilyName>Cool</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>VB</Initials>
                    <FamilyName>Mahesh</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Regulation of the human serotonin transporter. Cholera toxin-induced stimulation of serotonin uptake in human placental choriocarcinoma cells is accompanied by increased serotonin transporter mRNA levels and serotonin transporter-specific ligand binding</ArticleTitle>
                  <JournalTitle>J Biol Chem</JournalTitle>
                  <VolumeID>268</VolumeID>
                  <FirstPage>21626</FirstPage>
                  <LastPage>21631</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8408014</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3sXlsFamtbw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ramamoorthy S, Cool DR, Mahesh VB, et al. Regulation of the human serotonin transporter. Cholera toxin-induced stimulation of serotonin uptake in human placental choriocarcinoma cells is accompanied by increased serotonin transporter mRNA levels and serotonin transporter-specific ligand binding.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 1993;268:21626–21631.</BibUnstructured>
              </Citation>
              <Citation ID="CR29">
                <CitationNumber>29.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CB</Initials>
                    <FamilyName>Zhu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WA</Initials>
                    <FamilyName>Hewlett</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Feoktistov</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Biaggioni</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RD</Initials>
                    <FamilyName>Blakely</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation</ArticleTitle>
                  <JournalTitle>Mol Pharmacol</JournalTitle>
                  <VolumeID>65</VolumeID>
                  <FirstPage>1462</FirstPage>
                  <LastPage>1474</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15155839</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/mol.65.6.1462</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXksFagt7w%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zhu CB, Hewlett WA, Feoktistov I, Biaggioni I, Blakely RD. Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 2004;65:1462–1474.</BibUnstructured>
              </Citation>
              <Citation ID="CR30">
                <CitationNumber>30.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>KJ</Initials>
                    <FamilyName>Miller</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BJ</Initials>
                    <FamilyName>Hoffman</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">Adenosine A3 receptors regulate serotonin transport via nitric oxide and cGMP</ArticleTitle>
                  <JournalTitle>J Biol Chem</JournalTitle>
                  <VolumeID>269</VolumeID>
                  <FirstPage>27351</FirstPage>
                  <LastPage>27356</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7525554</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXmt1aks7w%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Miller KJ, Hoffman BJ. Adenosine A3 receptors regulate serotonin transport via nitric oxide and cGMP.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 1994;269:27351–27356.</BibUnstructured>
              </Citation>
              <Citation ID="CR31">
                <CitationNumber>31.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DJ</Initials>
                    <FamilyName>Samuvel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LD</Initials>
                    <FamilyName>Jayanthi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NR</Initials>
                    <FamilyName>Bhat</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Ramamoorthy</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: evidence for distinct cellular mechanisms involved in transporter surface expression</ArticleTitle>
                  <JournalTitle>J Neurosci</JournalTitle>
                  <VolumeID>25</VolumeID>
                  <FirstPage>29</FirstPage>
                  <LastPage>41</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15634764</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1523/JNEUROSCI.3754-04.2005</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXhtVWkurk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Samuvel DJ, Jayanthi LD, Bhat NR, Ramamoorthy S. A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: evidence for distinct cellular mechanisms involved in transporter surface expression.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2005;25:29–41.</BibUnstructured>
              </Citation>
              <Citation ID="CR32">
                <CitationNumber>32.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Haase</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AM</Initials>
                    <FamilyName>Killian</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Magnani</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Williams</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Regulation of the serotonin transporter by interacting proteins</ArticleTitle>
                  <JournalTitle>Biochem Soc Trans</JournalTitle>
                  <VolumeID>29</VolumeID>
                  <FirstPage>722</FirstPage>
                  <LastPage>728</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11709063</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1042/BST0290722</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXpt1CrsL8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Haase J, Killian AM, Magnani F, Williams C. Regulation of the serotonin transporter by interacting proteins.<Emphasis Type="Italic">Biochem Soc Trans</Emphasis>. 2001;29:722–728.</BibUnstructured>
              </Citation>
              <Citation ID="CR33">
                <CitationNumber>33.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MW</Initials>
                    <FamilyName>Quick</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Role of syntaxin 1A on serotonin transporter expression in developing thalamocortical neurons</ArticleTitle>
                  <JournalTitle>Int J Dev Neurosci</JournalTitle>
                  <VolumeID>20</VolumeID>
                  <FirstPage>219</FirstPage>
                  <LastPage>224</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12175857</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0736-5748(02)00021-7</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XmtlemtLY%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Quick MW. Role of syntaxin 1A on serotonin transporter expression in developing thalamocortical neurons.<Emphasis Type="Italic">Int J Dev Neurosci</Emphasis>. 2002;20:219–224.</BibUnstructured>
              </Citation>
              <Citation ID="CR34">
                <CitationNumber>34.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MW</Initials>
                    <FamilyName>Quick</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Regulating the conducting states of a mammalian serotonin transporter</ArticleTitle>
                  <JournalTitle>Neuron</JournalTitle>
                  <VolumeID>40</VolumeID>
                  <FirstPage>537</FirstPage>
                  <LastPage>549</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14642278</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0896-6273(03)00605-6</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXptVylu7w%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Quick MW. Regulating the conducting states of a mammalian serotonin transporter.<Emphasis Type="Italic">Neuron</Emphasis>. 2003;40:537–549.</BibUnstructured>
              </Citation>
              <Citation ID="CR35">
                <CitationNumber>35.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AL</Initials>
                    <FamilyName>Bauman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Apparsundaram</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Ramamoorthy</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BE</Initials>
                    <FamilyName>Wadzinski</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RA</Initials>
                    <FamilyName>Vaughan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RD</Initials>
                    <FamilyName>Blakely</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A</ArticleTitle>
                  <JournalTitle>J Neurosci</JournalTitle>
                  <VolumeID>20</VolumeID>
                  <FirstPage>7571</FirstPage>
                  <LastPage>7578</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11027216</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXns1eisL4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bauman AL, Apparsundaram S, Ramamoorthy S, Wadzinski BE, Vaughan RA, Blakely RD. Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2000;20:7571–7578.</BibUnstructured>
              </Citation>
              <Citation ID="CR36">
                <CitationNumber>36.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JL</Initials>
                    <FamilyName>Rausch</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CF</Initials>
                    <FamilyName>Gillespie</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Fei</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Antidepressant effects on kinase gene expression patterns in rat brain</ArticleTitle>
                  <JournalTitle>Neurosci Lett</JournalTitle>
                  <VolumeID>334</VolumeID>
                  <FirstPage>91</FirstPage>
                  <LastPage>94</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12435479</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0304-3940(02)01106-0</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XosFClurY%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Rausch JL, Gillespie CF, Fei Y. Antidepressant effects on kinase gene expression patterns in rat brain.<Emphasis Type="Italic">Neurosci Lett</Emphasis>. 2002;334:91–94.</BibUnstructured>
              </Citation>
              <Citation ID="CR37">
                <CitationNumber>37.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AJ</Initials>
                    <FamilyName>Gelenberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CL</Initials>
                    <FamilyName>Chesen</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">How fast are antidepressants?</ArticleTitle>
                  <JournalTitle>J Clin Psychiatry</JournalTitle>
                  <VolumeID>61</VolumeID>
                  <FirstPage>712</FirstPage>
                  <LastPage>721</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11078031</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXosFygsb4%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.4088/JCP.v61n1002</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Gelenberg AJ, Chesen CL. How fast are antidepressants?.<Emphasis Type="Italic">J Clin Psychiatry</Emphasis>. 2000;61:712–721.</BibUnstructured>
              </Citation>
              <Citation ID="CR38">
                <CitationNumber>38.</CitationNumber>
                <BibChapter>
                  <BibAuthorName>
                    <Initials>WZ</Initials>
                    <FamilyName>Potter</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LE</Initials>
                    <FamilyName>Hollister</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ChapterTitle Language="En">Antidepressant agents</ChapterTitle>
                  <BibEditorName>
                    <Initials>BG</Initials>
                    <FamilyName>Katzung</FamilyName>
                  </BibEditorName>
                  <Eds/>
                  <BookTitle>Basic &amp; Clinical Pharmacology</BookTitle>
                  <PublisherName>Lange Medical Books/McGraw-Hill</PublisherName>
                  <PublisherLocation>New York</PublisherLocation>
                  <FirstPage>482</FirstPage>
                  <LastPage>496</LastPage>
                </BibChapter>
                <BibUnstructured>Potter WZ, Hollister LE. Antidepressant agents. In: Katzung BG, ed.<Emphasis Type="Italic">Basic &amp; Clinical Pharmacology</Emphasis>. New York: Lange Medical Books/McGraw-Hill; 2004:482–496.</BibUnstructured>
              </Citation>
              <Citation ID="CR39">
                <CitationNumber>39.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Horschitz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Hummerich</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Schloss</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Down-regulation of the rat serotonin transporter upon exposure to a selective serotonin reuptake inhibitor</ArticleTitle>
                  <JournalTitle>Neuroreport</JournalTitle>
                  <VolumeID>12</VolumeID>
                  <FirstPage>2181</FirstPage>
                  <LastPage>2184</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11447330</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1097/00001756-200107200-00027</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXls1emsr8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Horschitz S, Hummerich R, Schloss P. Down-regulation of the rat serotonin transporter upon exposure to a selective serotonin reuptake inhibitor.<Emphasis Type="Italic">Neuroreport</Emphasis>. 2001;12: 2181–2184.</BibUnstructured>
              </Citation>
              <Citation ID="CR40">
                <CitationNumber>40.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Benmansour</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Cecchi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DA</Initials>
                    <FamilyName>Morilak</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level</ArticleTitle>
                  <JournalTitle>J Neurosci</JournalTitle>
                  <VolumeID>19</VolumeID>
                  <FirstPage>10494</FirstPage>
                  <LastPage>10501</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10575045</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXnslyrtbg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Benmansour S, Cecchi M, Morilak DA. Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level.<Emphasis Type="Italic">J Neurosci</Emphasis>. 1999;19:10494–10501.</BibUnstructured>
              </Citation>
              <Citation ID="CR41">
                <CitationNumber>41.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Benmansour</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WA</Initials>
                    <FamilyName>Owens</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Cecchi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DA</Initials>
                    <FamilyName>Morilak</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Frazer</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter</ArticleTitle>
                  <JournalTitle>J Neurosci</JournalTitle>
                  <VolumeID>22</VolumeID>
                  <FirstPage>6766</FirstPage>
                  <LastPage>6772</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12151556</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XlvFKnt7Y%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Benmansour S, Owens WA, Cecchi M, Morilak DA, Frazer A. Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2002;22:6766–6772.</BibUnstructured>
              </Citation>
              <Citation ID="CR42">
                <CitationNumber>42.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>GG</Initials>
                    <FamilyName>Gould</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MC</Initials>
                    <FamilyName>Pardon</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DA</Initials>
                    <FamilyName>Morilak</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Frazer</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Regulatory effects of reboxetine treatment alone, or following paroxetine treatment, on brain noradrenergic and serotonergic systems</ArticleTitle>
                  <JournalTitle>Neuropsychopharmacology</JournalTitle>
                  <VolumeID>28</VolumeID>
                  <FirstPage>1633</FirstPage>
                  <LastPage>1641</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12825093</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.npp.1300236</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXmsFeisLk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Gould GG, Pardon MC, Morilak DA, Frazer A. Regulatory effects of reboxetine treatment alone, or following paroxetine treatment, on brain noradrenergic and serotonergic systems.<Emphasis Type="Italic">Neuropsychopharmacology</Emphasis>. 2003;28:1633–1641.</BibUnstructured>
              </Citation>
              <Citation ID="CR43">
                <CitationNumber>43.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Kugaya</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NM</Initials>
                    <FamilyName>Seneca</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PJ</Initials>
                    <FamilyName>Snyder</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Changes in human<Emphasis Type="Italic">in vivo</Emphasis> serotonin and dopamine transporter availabilities during chronic antidepressant administration</ArticleTitle>
                  <JournalTitle>Neuropsychopharmacology</JournalTitle>
                  <VolumeID>28</VolumeID>
                  <FirstPage>413</FirstPage>
                  <LastPage>420</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12589396</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.npp.1300036</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXhtFGhsbc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kugaya A, Seneca NM, Snyder PJ, et al. Changes in human<Emphasis Type="Italic">in vivo</Emphasis> serotonin and dopamine transporter availabilities during chronic antidepressant administration.<Emphasis Type="Italic">Neuropsychopharmacology</Emphasis>. 2003;28:413–420.</BibUnstructured>
              </Citation>
              <Citation ID="CR44">
                <CitationNumber>44.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Plein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Berk</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">The platelet as a peripheral marker in psychiatric illness</ArticleTitle>
                  <JournalTitle>Hum Psychopharmacol</JournalTitle>
                  <VolumeID>16</VolumeID>
                  <FirstPage>229</FirstPage>
                  <LastPage>236</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12404575</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/hup.251</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXjvFKhu78%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Plein H, Berk M. The platelet as a peripheral marker in psychiatric illness.<Emphasis Type="Italic">Hum Psychopharmacol</Emphasis>. 2001;16:229–236.</BibUnstructured>
              </Citation>
              <Citation ID="CR45">
                <CitationNumber>45.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JC</Initials>
                    <FamilyName>Alvarez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Gluck</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Arnulf</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine</ArticleTitle>
                  <JournalTitle>Clin Pharmacol Ther</JournalTitle>
                  <VolumeID>66</VolumeID>
                  <FirstPage>617</FirstPage>
                  <LastPage>624</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10613618</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXlsVamsQ%3D%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1053/cp.1999.v66.103402001</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Alvarez JC, Gluck N, Arnulf I, et al. Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine.<Emphasis Type="Italic">Clin Pharmacol Ther</Emphasis>. 1999;66:617–624.</BibUnstructured>
              </Citation>
              <Citation ID="CR46">
                <CitationNumber>46.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Hébert</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Habimana</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Élie</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TA</Initials>
                    <FamilyName>Reader</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Effects of chronic antidepressant treatments on 5-HT and NA transporters in rat brain: an autoradiographic study</ArticleTitle>
                  <JournalTitle>Neurochem Int.</JournalTitle>
                  <VolumeID>38</VolumeID>
                  <FirstPage>63</FirstPage>
                  <LastPage>74</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10913689</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0197-0186(00)00043-7</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hébert C, Habimana A, Élie R, Reader TA. Effects of chronic antidepressant treatments on 5-HT and NA transporters in rat brain: an autoradiographic study.<Emphasis Type="Italic">Neurochem Int.</Emphasis> 2001;38:63–74.</BibUnstructured>
              </Citation>
              <Citation ID="CR47">
                <CitationNumber>47.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JL</Initials>
                    <FamilyName>Yau</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PA</Initials>
                    <FamilyName>Kelly</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Olsson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Noble</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JR</Initials>
                    <FamilyName>Seckl</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Chronic amitriptyline administration increases serotonin transporter binding sites in the hippocampus of aged rats</ArticleTitle>
                  <JournalTitle>Neurosci Lett</JournalTitle>
                  <VolumeID>261</VolumeID>
                  <FirstPage>183</FirstPage>
                  <LastPage>185</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10081979</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0304-3940(98)00997-5</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXhtFeisrc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Yau JL, Kelly PA, Olsson T, Noble J, Seckl JR. Chronic amitriptyline administration increases serotonin transporter binding sites in the hippocampus of aged rats.<Emphasis Type="Italic">Neurosci Lett</Emphasis>. 1999;261:183–185.</BibUnstructured>
              </Citation>
              <Citation ID="CR48">
                <CitationNumber>48.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Lima</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Urbina</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Serotonin transporter modulation in blood lymphocytes from patients with major depression</ArticleTitle>
                  <JournalTitle>Cell Mol Neurobiol</JournalTitle>
                  <VolumeID>22</VolumeID>
                  <FirstPage>797</FirstPage>
                  <LastPage>804</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12585696</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1023/A:1021869310702</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXhsFeiuw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lima L, Urbina M. Serotonin transporter modulation in blood lymphocytes from patients with major depression.<Emphasis Type="Italic">Cell Mol Neurobiol</Emphasis>. 2002;22:797–804.</BibUnstructured>
              </Citation>
              <Citation ID="CR49">
                <CitationNumber>49.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Schloss</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>FA</Initials>
                    <FamilyName>Henn</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">New insights into the mechanisms of antidepressant therapy</ArticleTitle>
                  <JournalTitle>Pharmacol Ther</JournalTitle>
                  <VolumeID>102</VolumeID>
                  <FirstPage>47</FirstPage>
                  <LastPage>60</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15056498</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.pharmthera.2004.02.001</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXisl2ktLw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Schloss P, Henn FA. New insights into the mechanisms of antidepressant therapy.<Emphasis Type="Italic">Pharmacol Ther</Emphasis>. 2004;102:47–60.</BibUnstructured>
              </Citation>
              <Citation ID="CR50">
                <CitationNumber>50.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Piñeyro</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Blier</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Autoregulation of serotonin neurons: role in antidepressant drug action</ArticleTitle>
                  <JournalTitle>Pharmacol Rev</JournalTitle>
                  <VolumeID>51</VolumeID>
                  <FirstPage>533</FirstPage>
                  <LastPage>591</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10471417</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Piñeyro G, Blier P. Autoregulation of serotonin neurons: role in antidepressant drug action.<Emphasis Type="Italic">Pharmacol Rev</Emphasis>. 1999;51:533–591.</BibUnstructured>
              </Citation>
              <Citation ID="CR51">
                <CitationNumber>51.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Celada</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Puig</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Amargos-Bosch</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Adell</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Artigas</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">The therapeutic role of 5-HT1A and 5-HT2A receptors in depression</ArticleTitle>
                  <JournalTitle>J Psychiatry Neurosci</JournalTitle>
                  <VolumeID>29</VolumeID>
                  <FirstPage>252</FirstPage>
                  <LastPage>265</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15309042</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Celada P, Puig M, Amargos-Bosch M, Adell A, Artigas F. The therapeutic role of 5-HT1A and 5-HT2A receptors in depression.<Emphasis Type="Italic">J Psychiatry Neurosci</Emphasis>. 2004;29:252–265.</BibUnstructured>
              </Citation>
              <Citation ID="CR52">
                <CitationNumber>52.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JG</Initials>
                    <FamilyName>Hensler</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Differential regulation of 5-HT1A receptor-G protein interactions in brain following chronic antidepressant administration</ArticleTitle>
                  <JournalTitle>Neuropsychopharmacology</JournalTitle>
                  <VolumeID>26</VolumeID>
                  <FirstPage>565</FirstPage>
                  <LastPage>573</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11927181</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0893-133X(01)00395-5</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xitlaru70%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hensler JG. Differential regulation of 5-HT1A receptor-G protein interactions in brain following chronic antidepressant administration.<Emphasis Type="Italic">Neuropsychopharmacology</Emphasis>. 2002;26:565–573.</BibUnstructured>
              </Citation>
              <Citation ID="CR53">
                <CitationNumber>53.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AR</Initials>
                    <FamilyName>Ase</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TA</Initials>
                    <FamilyName>Reader</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Hen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Riad</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Descarries</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Regional changes in density of serotonin transporter in the brain of 5-HT1A and 5-HT1B knockout mice, and of serotonin innervation in the 5-HT1B knockout</ArticleTitle>
                  <JournalTitle>J Neurochem</JournalTitle>
                  <VolumeID>78</VolumeID>
                  <FirstPage>619</FirstPage>
                  <LastPage>630</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11483665</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1046/j.1471-4159.2001.00437.x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXlvFWju7k%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ase AR, Reader TA, Hen R, Riad M, Descarries L Regional changes in density of serotonin transporter in the brain of 5-HT1A and 5-HT1B knockout mice, and of serotonin innervation in the 5-HT1B knockout.<Emphasis Type="Italic">J Neurochem</Emphasis>. 2001;78:619–630.</BibUnstructured>
              </Citation>
              <Citation ID="CR54">
                <CitationNumber>54.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LC</Initials>
                    <FamilyName>Daws</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GA</Initials>
                    <FamilyName>Gerhardt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Frazer</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">5-HT1B antagonists modulate clearance of extracellular serotonin in rat hippocampus</ArticleTitle>
                  <JournalTitle>Neurosci Lett</JournalTitle>
                  <VolumeID>266</VolumeID>
                  <FirstPage>165</FirstPage>
                  <LastPage>168</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10465699</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0304-3940(99)00277-3</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXjsVSgtLo%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Daws LC, Gerhardt GA, Frazer A. 5-HT1B antagonists modulate clearance of extracellular serotonin in rat hippocampus.<Emphasis Type="Italic">Neurosci Lett</Emphasis>. 1999;266:165–168.</BibUnstructured>
              </Citation>
              <Citation ID="CR55">
                <CitationNumber>55.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LC</Initials>
                    <FamilyName>Daws</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GG</Initials>
                    <FamilyName>Gould</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SD</Initials>
                    <FamilyName>Teicher</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GA</Initials>
                    <FamilyName>Gerhardt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Frazer</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">5-HT(1B) receptor-mediated regulation of serotonin clearance in rat hippocampus in vivo</ArticleTitle>
                  <JournalTitle>J Neurochem</JournalTitle>
                  <VolumeID>75</VolumeID>
                  <FirstPage>2113</FirstPage>
                  <LastPage>2122</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11032901</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1046/j.1471-4159.2000.0752113.x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXns1eju7s%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Daws LC, Gould GG, Teicher SD, Gerhardt GA, Frazer A. 5-HT(1B) receptor-mediated regulation of serotonin clearance in rat hippocampus in vivo.<Emphasis Type="Italic">J Neurochem</Emphasis>. 2000;75:2113–2122.</BibUnstructured>
              </Citation>
              <Citation ID="CR56">
                <CitationNumber>56.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Malagié</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DJ</Initials>
                    <FamilyName>David</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Jolliet</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Hen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Bourin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AM</Initials>
                    <FamilyName>Gardier</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Improved efficacy of fluoxetine in increasing hippocampal 5-hydroxytryptamine outflow in 5-HT1B receptor knock-out mice</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol</JournalTitle>
                  <VolumeID>443</VolumeID>
                  <FirstPage>99</FirstPage>
                  <LastPage>104</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12044798</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0014-2999(02)01604-7</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Malagié I, David DJ, Jolliet P, Hen R, Bourin M, Gardier AM. Improved efficacy of fluoxetine in increasing hippocampal 5-hydroxytryptamine outflow in 5-HT1B receptor knock-out mice.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 2002;443:99–104.</BibUnstructured>
              </Citation>
              <Citation ID="CR57">
                <CitationNumber>57.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JF</Initials>
                    <FamilyName>Neumaier</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DC</Initials>
                    <FamilyName>Root</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MW</Initials>
                    <FamilyName>Hamblin</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Chronic fluoxetine reduces serotonin transporter mRNA and 5-HT1B mRNA in a sequential manner in the rat dorsal raphe nucleus</ArticleTitle>
                  <JournalTitle>Neuropsychopharmacology</JournalTitle>
                  <VolumeID>15</VolumeID>
                  <FirstPage>515</FirstPage>
                  <LastPage>522</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8914125</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0893-133X(96)00095-4</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XmvFWktLo%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Neumaier JF, Root DC, Hamblin MW. Chronic fluoxetine reduces serotonin transporter mRNA and 5-HT1B mRNA in a sequential manner in the rat dorsal raphe nucleus.<Emphasis Type="Italic">Neuropsychopharmacology</Emphasis>. 1996;15:515–522.</BibUnstructured>
              </Citation>
              <Citation ID="CR58">
                <CitationNumber>58.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Artigas</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Perez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Alvarez</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors</ArticleTitle>
                  <JournalTitle>Arch Gen Psychiatry</JournalTitle>
                  <VolumeID>51</VolumeID>
                  <FirstPage>248</FirstPage>
                  <LastPage>251</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8122960</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK2c7mvVGitw%3D%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1001/archpsyc.1994.03950030084009</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Artigas F, Perez V, Alvarez E. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors.<Emphasis Type="Italic">Arch Gen Psychiatry</Emphasis>. 1994;51:248–251.</BibUnstructured>
              </Citation>
              <Citation ID="CR59">
                <CitationNumber>59.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Shalom</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Gur</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LD</Initials>
                    <FamilyName>Kar</FamilyName>
                    <Particle>Van de</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ME</Initials>
                    <FamilyName>Newman</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Repeated administration of the 5-HT(1B) receptor antagonist SB-224289 blocks the desensitisation of 5-HT(1B) autoreceptors induced by fluoxetine in rat frontal cortex</ArticleTitle>
                  <JournalTitle>Naunyn Schmiedebergs Arch Pharmacol</JournalTitle>
                  <VolumeID>370</VolumeID>
                  <FirstPage>84</FirstPage>
                  <LastPage>90</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15309378</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/s00210-004-0958-x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXoslyrtr0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Shalom G, Gur, E, Van de Kar LD, Newman ME. Repeated administration of the 5-HT(1B) receptor antagonist SB-224289 blocks the desensitisation of 5-HT(1B) autoreceptors induced by fluoxetine in rat frontal cortex.<Emphasis Type="Italic">Naunyn Schmiedebergs Arch Pharmacol</Emphasis>. 2004;370:84–90.</BibUnstructured>
              </Citation>
              <Citation ID="CR60">
                <CitationNumber>60.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>TA</Initials>
                    <FamilyName>Ansah</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Ramamoorthy</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Montanez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LC</Initials>
                    <FamilyName>Daws</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RD</Initials>
                    <FamilyName>Blakely</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Calcium-dependent inhibition of synaptosomal serotonin transport by the alpha 2-adrenoceptor agonist 5-bromo-N-[4,5-dihydro-1H-imidazol-2-yl]-6-quinoxalinamine (UK14304)</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>305</VolumeID>
                  <FirstPage>956</FirstPage>
                  <LastPage>965</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12626658</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/jpet.102.047134</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXkt1Snsb4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ansah TA, Ramamoorthy S, Montanez S, Daws LC, Blakely RD. Calcium-dependent inhibition of synaptosomal serotonin transport by the alpha 2-adrenoceptor agonist 5-bromo-N-[4,5-dihydro-1H-imidazol-2-yl]-6-quinoxalinamine (UK14304).<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2003;305:956–965.</BibUnstructured>
              </Citation>
              <Citation ID="CR61">
                <CitationNumber>61.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Ramamoorthy</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AL</Initials>
                    <FamilyName>Bauman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KR</Initials>
                    <FamilyName>Moore</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>90</VolumeID>
                  <FirstPage>2542</FirstPage>
                  <LastPage>2546</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7681602</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.90.6.2542</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3sXkvV2gsrs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ramamoorthy S, Bauman AL, Moore KR, et al. Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 1993;90:2542–2546.</BibUnstructured>
              </Citation>
              <Citation ID="CR62">
                <CitationNumber>62.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Heils</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Teufel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Petri</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Allelic variation of human serotonin transporter gene expression</ArticleTitle>
                  <JournalTitle>J Neurochem</JournalTitle>
                  <VolumeID>66</VolumeID>
                  <FirstPage>2621</FirstPage>
                  <LastPage>2624</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8632190</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XjtFCrsrk%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1046/j.1471-4159.1996.66062621.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Heils A, Teufel A, Petri S, et al. Allelic variation of human serotonin transporter gene expression.<Emphasis Type="Italic">J Neurochem</Emphasis>. 1996;66:2621–2624.</BibUnstructured>
              </Citation>
              <Citation ID="CR63">
                <CitationNumber>63.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>KP</Initials>
                    <FamilyName>Lesch</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Bengel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Heils</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region</ArticleTitle>
                  <JournalTitle>Science</JournalTitle>
                  <VolumeID>274</VolumeID>
                  <FirstPage>1527</FirstPage>
                  <LastPage>1531</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8929413</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1126/science.274.5292.1527</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28Xnt1ansL8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lesch KP, Bengel D, Heils A, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region.<Emphasis Type="Italic">Science</Emphasis>. 1996;274:1527–1531.</BibUnstructured>
              </Citation>
              <Citation ID="CR64">
                <CitationNumber>64.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JL</Initials>
                    <FamilyName>Rausch</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ME</Initials>
                    <FamilyName>Johnson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>YJ</Initials>
                    <FamilyName>Fei</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome</ArticleTitle>
                  <JournalTitle>Biol Psychiatry</JournalTitle>
                  <VolumeID>51</VolumeID>
                  <FirstPage>723</FirstPage>
                  <LastPage>732</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11983186</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0006-3223(01)01283-5</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xjt1SgtLk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Rausch JL, Johnson ME, Fei YJ, et al. Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome.<Emphasis Type="Italic">Biol Psychiatry</Emphasis>. 2002;51:723–732.</BibUnstructured>
              </Citation>
              <Citation ID="CR65">
                <CitationNumber>65.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>YW</Initials>
                    <FamilyName>Yu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SJ</Initials>
                    <FamilyName>Tsai</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TJ</Initials>
                    <FamilyName>Chen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CH</Initials>
                    <FamilyName>Lin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CJ</Initials>
                    <FamilyName>Hong</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders</ArticleTitle>
                  <JournalTitle>Mol Psychiatry</JournalTitle>
                  <VolumeID>7</VolumeID>
                  <FirstPage>1115</FirstPage>
                  <LastPage>1119</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12476327</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.mp.4001141</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XptlyksL8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Yu YW, Tsai SJ, Chen TJ, Lin CH, Hong CJ. Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders.<Emphasis Type="Italic">Mol Psychiatry</Emphasis>. 2002;7:1115–1119.</BibUnstructured>
              </Citation>
              <Citation ID="CR66">
                <CitationNumber>66.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>BG</Initials>
                    <FamilyName>Pollock</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RE</Initials>
                    <FamilyName>Ferrell</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BH</Initials>
                    <FamilyName>Mulsant</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression</ArticleTitle>
                  <JournalTitle>Neuropsychopharmacology</JournalTitle>
                  <VolumeID>23</VolumeID>
                  <FirstPage>587</FirstPage>
                  <LastPage>590</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11027924</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0893-133X(00)00132-9</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXntF2hsr4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Pollock BG, Ferrell RE, Mulsant BH, et al. Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression.<Emphasis Type="Italic">Neuropsychopharmacology</Emphasis>. 2000;23:587–590.</BibUnstructured>
              </Citation>
              <Citation ID="CR67">
                <CitationNumber>67.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LK</Initials>
                    <FamilyName>Durham</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SM</Initials>
                    <FamilyName>Webb</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PM</Initials>
                    <FamilyName>Milos</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CM</Initials>
                    <FamilyName>Clary</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AB</Initials>
                    <FamilyName>Seymour</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder</ArticleTitle>
                  <JournalTitle>Psychopharmacology (Berl)</JournalTitle>
                  <VolumeID>174</VolumeID>
                  <FirstPage>525</FirstPage>
                  <LastPage>529</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/s00213-003-1562-3</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXms1Ogtb0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Durham LK, Webb SM, Milos PM, Clary CM, Seymour AB. The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder.<Emphasis Type="Italic">Psychopharmacology (Berl)</Emphasis>. 2004;174:525–529.</BibUnstructured>
              </Citation>
              <Citation ID="CR68">
                <CitationNumber>68.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Ozaki</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Goldman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WH</Initials>
                    <FamilyName>Kaye</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype</ArticleTitle>
                  <JournalTitle>Mol Psychiatry</JournalTitle>
                  <VolumeID>8</VolumeID>
                  <FirstPage>933</FirstPage>
                  <LastPage>936</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14593431</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.mp.4001365</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXosFajt70%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ozaki N, Goldman D, Kaye WH, et al. Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype.<Emphasis Type="Italic">Mol Psychiatry</Emphasis>. 2003;8:933–936.</BibUnstructured>
              </Citation>
              <Citation ID="CR69">
                <CitationNumber>69.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Kilic</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DL</Initials>
                    <FamilyName>Murphy</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Rudnick</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">A human serotonin transporter mutation causes constitutive activation of transport activity</ArticleTitle>
                  <JournalTitle>Mol Pharmacol</JournalTitle>
                  <VolumeID>64</VolumeID>
                  <FirstPage>440</FirstPage>
                  <LastPage>446</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12869649</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/mol.64.2.440</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXlvVCnsL0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kilic F, Murphy DL, Rudnick G. A human serotonin transporter mutation causes constitutive activation of transport activity.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 2003;64:440–446.</BibUnstructured>
              </Citation>
              <Citation ID="CR70">
                <CitationNumber>70.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RS</Initials>
                    <FamilyName>Smith</FamilyName>
                  </BibAuthorName>
                  <Year>1991</Year>
                  <ArticleTitle Language="En">The macrophage theory of depression</ArticleTitle>
                  <JournalTitle>Med Hypotheses</JournalTitle>
                  <VolumeID>35</VolumeID>
                  <FirstPage>298</FirstPage>
                  <LastPage>306</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1943879</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0306-9877(91)90272-Z</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK38%2FkvVOmsw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Smith RS. The macrophage theory of depression.<Emphasis Type="Italic">Med Hypotheses</Emphasis>. 1991;35:298–306.</BibUnstructured>
              </Citation>
              <Citation ID="CR71">
                <CitationNumber>71.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>TJ</Initials>
                    <FamilyName>Connor</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BE</Initials>
                    <FamilyName>Leonard</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Depression stress and immunological activation: the role of cytokines in depressive disorders</ArticleTitle>
                  <JournalTitle>Life Sci</JournalTitle>
                  <VolumeID>62</VolumeID>
                  <FirstPage>583</FirstPage>
                  <LastPage>606</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9472719</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0024-3205(97)00990-9</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXlsVGmuw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Connor TJ, Leonard BE. Depression stress and immunological activation: the role of cytokines in depressive disorders.<Emphasis Type="Italic">Life Sci</Emphasis>. 1998;62:583–606.</BibUnstructured>
              </Citation>
              <Citation ID="CR72">
                <CitationNumber>72.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Pfennig</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HE</Initials>
                    <FamilyName>Kunzel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Kern</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression</ArticleTitle>
                  <JournalTitle>Biol Psychiatry</JournalTitle>
                  <VolumeID>57</VolumeID>
                  <FirstPage>336</FirstPage>
                  <LastPage>342</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15705348</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.biopsych.2004.11.017</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXhtlaisbs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Pfennig A, Kunzel HE, Kern N, et al. Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression.<Emphasis Type="Italic">Biol Psychiatry</Emphasis>. 2005;57:336–342.</BibUnstructured>
              </Citation>
              <Citation ID="CR73">
                <CitationNumber>73.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Capuron</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Ravaud</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PJ</Initials>
                    <FamilyName>Neveu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AH</Initials>
                    <FamilyName>Miller</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Maes</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Dantzer</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy</ArticleTitle>
                  <JournalTitle>Mol Psychiatry</JournalTitle>
                  <VolumeID>7</VolumeID>
                  <FirstPage>468</FirstPage>
                  <LastPage>473</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12082564</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.mp.4000995</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XkslKmtr8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Capuron L, Ravaud A, Neveu PJ, Miller AH, Maes M, Dantzer R. Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy.<Emphasis Type="Italic">Mol Psychiatry</Emphasis>. 2002;7:468–473.</BibUnstructured>
              </Citation>
              <Citation ID="CR74">
                <CitationNumber>74.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Capuron</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Neurauter</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DL</Initials>
                    <FamilyName>Musselman</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Interferon-alpha-induced changes in tryptophan metabolism: relationship to depression and paroxetine treatment</ArticleTitle>
                  <JournalTitle>Biol Psychiatry</JournalTitle>
                  <VolumeID>54</VolumeID>
                  <FirstPage>906</FirstPage>
                  <LastPage>914</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14573318</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0006-3223(03)00173-2</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXot1Omt78%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Capuron L, Neurauter G, Musselman DL, et al. Interferon-alpha-induced changes in tryptophan metabolism: relationship to depression and paroxetine treatment.<Emphasis Type="Italic">Biol Psychiatry</Emphasis>. 2003;54:906–914.</BibUnstructured>
              </Citation>
              <Citation ID="CR75">
                <CitationNumber>75.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>OJ</Initials>
                    <FamilyName>Schiepers</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MC</Initials>
                    <FamilyName>Wichers</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Maes</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Cytokines and major depression</ArticleTitle>
                  <JournalTitle>Prog Neuropsychopharmacol Biol Psychiatry</JournalTitle>
                  <VolumeID>29</VolumeID>
                  <FirstPage>201</FirstPage>
                  <LastPage>217</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15694227</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.pnpbp.2004.11.003</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXptlCqsQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Schiepers OJ, Wichers MC, Maes M. Cytokines and major depression.<Emphasis Type="Italic">Prog Neuropsychopharmacol Biol Psychiatry</Emphasis>. 2005;29:201–217.</BibUnstructured>
              </Citation>
              <Citation ID="CR76">
                <CitationNumber>76.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Bschor</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Baethge</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Adli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>U</Initials>
                    <FamilyName>Lewitzka</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>U</Initials>
                    <FamilyName>Eichmann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Bauer</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Hypothalamic-pituitary-thyroid system activity during lithium augm entation therapy in patients with unipolar major depression</ArticleTitle>
                  <JournalTitle>J Psychiatry Neurosci</JournalTitle>
                  <VolumeID>28</VolumeID>
                  <FirstPage>210</FirstPage>
                  <LastPage>216</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12790161</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bschor T, Baethge C, Adli M, Lewitzka U, Eichmann U, Bauer M. Hypothalamic-pituitary-thyroid system activity during lithium augm entation therapy in patients with unipolar major depression.<Emphasis Type="Italic">J Psychiatry Neurosci</Emphasis>. 2003;28:210–216.</BibUnstructured>
              </Citation>
              <Citation ID="CR77">
                <CitationNumber>77.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MF</Initials>
                    <FamilyName>Sauvage</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Marquet</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Rousseau</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Raby</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Buxeraud</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Lachatre</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Relationship between psychotropic drugs and thyroid function: a review</ArticleTitle>
                  <JournalTitle>Toxicol Appl Pharmacol</JournalTitle>
                  <VolumeID>149</VolumeID>
                  <FirstPage>127</FirstPage>
                  <LastPage>135</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9571980</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1006/taap.1998.8367</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK1c3jtlGjtQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sauvage MF, Marquet P, Rousseau A, Raby C, Buxeraud J, Lachatre G. Relationship between psychotropic drugs and thyroid function: a review.<Emphasis Type="Italic">Toxicol Appl Pharmacol</Emphasis>. 1998;149:127–135.</BibUnstructured>
              </Citation>
              <Citation ID="CR78">
                <CitationNumber>78.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RC</Initials>
                    <FamilyName>Shelton</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Winn</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Ekhatore</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PT</Initials>
                    <FamilyName>Loosen</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">The effects of antidepressants on the thyroid axis in depression</ArticleTitle>
                  <JournalTitle>Biol Psychiatry</JournalTitle>
                  <VolumeID>33</VolumeID>
                  <FirstPage>120</FirstPage>
                  <LastPage>126</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8439600</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0006-3223(93)90311-Z</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3sXhvVehur0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Shelton RC, Winn S, Ekhatore N, Loosen PT. The effects of antidepressants on the thyroid axis in depression.<Emphasis Type="Italic">Biol Psychiatry</Emphasis>. 1993;33:120–126.</BibUnstructured>
              </Citation>
              <Citation ID="CR79">
                <CitationNumber>79.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Duval</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MC</Initials>
                    <FamilyName>Mokrani</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MA</Initials>
                    <FamilyName>Crocq</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Effect of antidepressant medication on morning and evening thyroid function tests during a major depressive episode</ArticleTitle>
                  <JournalTitle>Arch Gen Psychiatry</JournalTitle>
                  <VolumeID>53</VolumeID>
                  <FirstPage>833</FirstPage>
                  <LastPage>840</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8792760</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK28zosV2jsg%3D%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1001/archpsyc.1996.01830090081012</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Duval F, Mokrani MC, Crocq MA, et al. Effect of antidepressant medication on morning and evening thyroid function tests during a major depressive episode.<Emphasis Type="Italic">Arch Gen Psychiatry</Emphasis>. 1996;53:833–840.</BibUnstructured>
              </Citation>
              <Citation ID="CR80">
                <CitationNumber>80.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Nibuya</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EJ</Initials>
                    <FamilyName>Nestler</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RS</Initials>
                    <FamilyName>Duman</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus</ArticleTitle>
                  <JournalTitle>J Neurosci</JournalTitle>
                  <VolumeID>16</VolumeID>
                  <FirstPage>2365</FirstPage>
                  <LastPage>2372</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8601816</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XhvVCksrw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Nibuya M, Nestler EJ, Duman RS. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus.<Emphasis Type="Italic">J Neurosci</Emphasis>. 1996;16:2365–2372.</BibUnstructured>
              </Citation>
              <Citation ID="CR81">
                <CitationNumber>81.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>TL</Initials>
                    <FamilyName>Wallace</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KE</Initials>
                    <FamilyName>Stellitano</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RL</Initials>
                    <FamilyName>Neve</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RS</Initials>
                    <FamilyName>Duman</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Effects of cyclic adenosine monophosphate response element binding protein overexpression in the basolateral amygdala on behavioral models of depression and anxiety</ArticleTitle>
                  <JournalTitle>Biol Psychiatry</JournalTitle>
                  <VolumeID>56</VolumeID>
                  <FirstPage>151</FirstPage>
                  <LastPage>160</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15271583</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.biopsych.2004.04.010</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXlvFyksLw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Wallace TL, Stellitano KE, Neve RL, Duman RS. Effects of cyclic adenosine monophosphate response element binding protein overexpression in the basolateral amygdala on behavioral models of depression and anxiety.<Emphasis Type="Italic">Biol Psychiatry</Emphasis>. 2004;56:151–160.</BibUnstructured>
              </Citation>
              <Citation ID="CR82">
                <CitationNumber>82.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Shimizu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Hashimoto</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Okamura</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants</ArticleTitle>
                  <JournalTitle>Biol Psychiatry</JournalTitle>
                  <VolumeID>54</VolumeID>
                  <FirstPage>70</FirstPage>
                  <LastPage>75</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12842310</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0006-3223(03)00181-1</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXkvF2jsro%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Shimizu E, Hashimoto K, Okamura N, et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants.<Emphasis Type="Italic">Biol Psychiatry</Emphasis>. 2003;54:70–75.</BibUnstructured>
              </Citation>
              <Citation ID="CR83">
                <CitationNumber>83.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RS</Initials>
                    <FamilyName>Duman</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Role of neurotrophic factors in the etiology and treatment of mood disorders</ArticleTitle>
                  <JournalTitle>Neuromolecular Med</JournalTitle>
                  <VolumeID>5</VolumeID>
                  <FirstPage>11</FirstPage>
                  <LastPage>25</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15001809</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1385/NMM:5:1:011</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXivVCiuro%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Duman RS. Role of neurotrophic factors in the etiology and treatment of mood disorders.<Emphasis Type="Italic">Neuromolecular Med</Emphasis>. 2004;5:11–25.</BibUnstructured>
              </Citation>
              <Citation ID="CR84">
                <CitationNumber>84.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AL</Initials>
                    <FamilyName>Coppell</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Q</Initials>
                    <FamilyName>Pei</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TS</Initials>
                    <FamilyName>Zetterstrom</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Bi-phasic change in BDNF gene expression following antidepressant drug treatment</ArticleTitle>
                  <JournalTitle>Neuropharmacology</JournalTitle>
                  <VolumeID>44</VolumeID>
                  <FirstPage>903</FirstPage>
                  <LastPage>910</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12726822</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0028-3908(03)00077-7</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXjt1Gqs78%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Coppell AL, Pei Q, Zetterstrom TS. Bi-phasic change in BDNF gene expression following antidepressant drug treatment.<Emphasis Type="Italic">Neuropharmacology</Emphasis>. 2003;44:903–910.</BibUnstructured>
              </Citation>
              <Citation ID="CR85">
                <CitationNumber>85.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AC</Initials>
                    <FamilyName>Conti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JF</Initials>
                    <FamilyName>Cryan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Dalvi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Lucki</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Blendy</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs</ArticleTitle>
                  <JournalTitle>J Neurosci</JournalTitle>
                  <VolumeID>22</VolumeID>
                  <FirstPage>3262</FirstPage>
                  <LastPage>3268</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11943827</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XjtF2gtL0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Conti AC, Cryan JF, Dalvi A, Lucki I, Blendy JA. cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2002;22:3262–3268.</BibUnstructured>
              </Citation>
              <Citation ID="CR86">
                <CitationNumber>86.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>IA</Initials>
                    <FamilyName>Pullar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JR</Initials>
                    <FamilyName>Boot</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RJ</Initials>
                    <FamilyName>Broadmore</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">The role of the 5-HT1D receptor as a presynaptic autoreceptor in the guinea pig</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol</JournalTitle>
                  <VolumeID>493</VolumeID>
                  <FirstPage>85</FirstPage>
                  <LastPage>93</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15189767</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.ejphar.2004.04.029</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXkvV2htro%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Pullar IA, Boot JR, Broadmore RJ. The role of the 5-HT1D receptor as a presynaptic autoreceptor in the guinea pig.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 2004;493:85–93.</BibUnstructured>
              </Citation>
              <Citation ID="CR87">
                <CitationNumber>87.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AH</Initials>
                    <FamilyName>Young</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Gallagher</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Watson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Del-Estal</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BM</Initials>
                    <FamilyName>Owen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Nicol Ferrier</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder</ArticleTitle>
                  <JournalTitle>Neuropsychopharmacology</JournalTitle>
                  <VolumeID>29</VolumeID>
                  <FirstPage>1538</FirstPage>
                  <LastPage>1545</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15127079</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.npp.1300471</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXlvVSjtrs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Young AH, Gallagher P, Watson S, Del-Estal D, Owen BM, Nicol Ferrier I. Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder.<Emphasis Type="Italic">Neuropsychopharmacology</Emphasis>. 2004;29:1538–1545.</BibUnstructured>
              </Citation>
              <Citation ID="CR88">
                <CitationNumber>88.</CitationNumber>
                <BibUnstructured>Bao AM, Hestiantoro A, Van Someren EJ, Swaab DF, Zhou JN. Colocalization of corticotropin-releasing hormone and oestrogen receptor-{alpha} in the paraventricular nucleus of the hypothalamus in mood disorders.<Emphasis Type="Italic">Brain</Emphasis>. 2005.</BibUnstructured>
              </Citation>
              <Citation ID="CR89">
                <CitationNumber>89.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LJ</Initials>
                    <FamilyName>Dableh</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Yashpal</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Rochford</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JL</Initials>
                    <FamilyName>Henry</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Antidepressant-like effects of neurokin receptor antagonists in the forced swim test in the rat</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol</JournalTitle>
                  <VolumeID>507</VolumeID>
                  <FirstPage>99</FirstPage>
                  <LastPage>105</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15659299</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.ejphar.2004.11.024</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXkvVCnug%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Dableh LJ, Yashpal K, Rochford J, Henry JL. Antidepressant-like effects of neurokin receptor antagonists in the forced swim test in the rat.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 2005;507:99–105.</BibUnstructured>
              </Citation>
            </Bibliography>
          </ArticleBackmatter>
        </Article>
      </Issue>
    </Volume>
  </Journal>
</Publisher>
